Informed-money record

ELVN · Enliven Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

1

Bearish filings

134

Named actors

16

Disclosed $ (bull / bear)

$0 / $148.4M

Recent disclosures

25 of 135 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-07-06Director Kunkel Lori Annesold$299KSEC ↗
2026-07-06Director Kunkel Lori Annesold$205KSEC ↗
2026-06-22Shareholder (via Jefferies LLC) The Biotech Growth Trust PLCfiled notice to sell$1.4MSEC ↗
2026-06-22Shareholder (via Morgan Stanley & Co. LLC) The Biotech Growth Trust PLCfiled notice to sell$80KSEC ↗
2026-06-22Shareholder (via Morgan Stanley & Co. LLC) OrbiMed Private Investments VII, LPfiled notice to sell$2.1MSEC ↗
2026-06-22Shareholder (via Jefferies LLC) OrbiMed Private Investments VII, LPfiled notice to sell$36.2MSEC ↗
2026-06-22Shareholder (via Jefferies LLC) OrbiMed Genesis Master Fund, L.P.filed notice to sell$1.1MSEC ↗
2026-06-22Shareholder (via Morgan Stanley & Co. LLC) OrbiMed Genesis Master Fund, L.P.filed notice to sell$68KSEC ↗
2026-06-2210% owner / other ORBIMED ADVISORS LLCsold$2.1MSEC ↗
2026-06-2210% owner / other ORBIMED ADVISORS LLCsold$66KSEC ↗
2026-06-2210% owner / other ORBIMED ADVISORS LLCsold$35.7MSEC ↗
2026-06-2210% owner / other ORBIMED ADVISORS LLCsold$1.1MSEC ↗
2026-06-17CHIEF MEDICAL OFFICER Collins Helen Louisesold$114KSEC ↗
2026-06-17CHIEF MEDICAL OFFICER Collins Helen Louisesold$51KSEC ↗
2026-06-17CHIEF MEDICAL OFFICER Collins Helen Louisesold$54KSEC ↗
2026-06-17CHIEF FINANCIAL OFFICER Hohl Benjaminsold$59KSEC ↗
2026-06-17CHIEF FINANCIAL OFFICER Hohl Benjaminsold$55KSEC ↗
2026-06-17CHIEF FINANCIAL OFFICER Hohl Benjaminsold$149KSEC ↗
2026-06-17Officer (via Jefferies LLC) Hohl Benjaminfiled notice to sell$768KSEC ↗
2026-06-15Shareholder (via Themis Trading LLC) OrbiMed Genesis Master Fund, L.P.filed notice to sell$385KSEC ↗
2026-06-15Shareholder (via Themis Trading LLC) OrbiMed Private Investments VII, LPfiled notice to sell$11.5MSEC ↗
2026-06-15Shareholder (via Themis Trading LLC) The Biotech Growth Trust PLCfiled notice to sell$434KSEC ↗
2026-06-1510% owner / other ORBIMED ADVISORS LLCsold$409KSEC ↗
2026-06-1510% owner / other ORBIMED ADVISORS LLCsold$12.3MSEC ↗
2026-06-12Issuer (share issuance)priced an offeringSEC ↗

110 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals